CHORDOMA
Clinical trials for CHORDOMA explained in plain language.
Never miss a new study
Get alerted when new CHORDOMA trials appear
Sign up with your email to follow new studies for CHORDOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer drug regorafenib tested to halt bone sarcoma spread
Disease control CompletedThis phase 2 trial tests whether the drug regorafenib can stop or slow the growth of metastatic bone sarcomas (cancers that started in bone and spread). 163 patients with osteosarcoma, Ewing sarcoma, chondrosarcoma, or chordoma are randomly assigned to receive regorafenib or a pl…
Matched conditions: CHORDOMA
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Promising drug combo targets rare spine tumor
Disease control CompletedThis early-phase study tested the safety of combining the drug nilotinib with standard radiation therapy for people with high-risk chordoma, a rare bone tumor. The goal was to find the highest safe dose of nilotinib that could be given alongside radiation without causing severe s…
Matched conditions: CHORDOMA
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC